drugset / Trial / NCT01295034

Vitamin D Supplements for HIV-positive Patients on cART

NCT01295034

RandomizedParallel-groupDouble-blindTreatment

Summary

The ability of vitamin D to modulate the immune system and strengthen bones may mitigate the adverse medication consequences of HIV/AIDS, but little is known about either the health benefits of vitamin D supplements, or about the optimal dosing regimen for patients on highly active antiretroviral therapy (HAART). This trial is a comparison of two regimens for administering vitamin D and calcium to HIV-positive individuals taking antiviral medications. This study will help physicians make evidence-based decisions about the most effective way to use vitamin D in their patients and enable the design of large multi-center trials in the future.

Timeline

Start
2011-03
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 1000 iu Oral
Subject Cholecalciferol Other / unclassified 2000 iu Oral
Subject Cholecalciferol Other / unclassified 4000 iu Oral
Subject Ergocalciferol Small molecule 50000 iu Oral